Treatment of Alcohol Withdrawal in Hospital Patients

• Status: Completed
• Trial end date: 2003-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test how tolerable and effective lorazepam is when used to treat alcohol withdrawal in hospital patients at risk for alcohol withdrawal.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Virginia Commonwealth University
• Collaborator: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
• Treatments: Ethanol; Lorazepam

Criteria

Inclusion Criteria:

• Alcohol dependence (based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition)

• Daily alcohol use for at least seven consecutive days with the last use no more than 72 hours prior to enrollment

• Patients on the General Internal Medicine service

Exclusion Criteria:

• Unable to give informed consent

• Chronically maintained on prescription sedative-hypnotics